Europe and Middle East and Africa Medical Oxygen Cylinder Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2032

Europe and Middle East and Africa Medical Oxygen Cylinder Market Size

• The Europe and Middle East and Africa medical oxygen cylinder market size was valued at USD 5.87 billion in 2024 and is expected to reach USD 8.88 billion by 2032, at a CAGR of 5.30% during the forecast period
• The market growth is largely fueled by the growing demand for respiratory care, home healthcare, and emergency medical services across both Europe and the Middle East & Africa (MEA). Technological advancements in oxygen storage systems and a rising aging population with chronic respiratory diseases such as COPD and asthma are contributing to the increased need for portable and efficient medical oxygen cylinders. The COVID-19 pandemic further heightened awareness and demand for oxygen therapy across healthcare facilities and homes, laying the groundwork for long-term market expansion
• Furthermore, rising consumer demand for accessible, reliable, and lightweight oxygen delivery systems is propelling the shift from stationary oxygen sources to portable oxygen cylinders. This shift is especially prominent in remote and underserved areas across MEA, where access to centralized oxygen generation facilities remains limited. As a result, portable oxygen cylinders are becoming essential in bridging the healthcare access gap

Europe and Middle East and Africa Medical Oxygen Cylinder Market Analysis

• Medical oxygen cylinders, offering portable and fixed oxygen delivery solutions for patients with respiratory conditions, are increasingly vital components of healthcare systems in both clinical and homecare settings due to their life-sustaining capabilities, portability, and role in emergency and chronic respiratory care
• The escalating demand for medical oxygen cylinders is primarily fueled by the growing prevalence of respiratory diseases (such as COPD, asthma, and COVID-19 aftereffects), increasing geriatric population, and the rising need for home-based oxygen therapy
• Europe dominated the Europe and Middle East and Africa medical oxygen cylinder market with the largest revenue share of 38.4% in 2024, characterized by advanced healthcare infrastructure, favorable reimbursement policies, and an increasing number of patients requiring long-term oxygen therapy. Germany, France, and the U.K. are witnessing substantial growth in cylinder installations across hospitals and homecare settings, driven by innovations in lightweight, high-capacity cylinders and demand for mobile respiratory support
• Middle East and Africa is expected to be the fastest growing region in the Europe and Middle East and Africa medical oxygen cylinder market, supported by improving healthcare access, government-led investments in oxygen supply infrastructure (especially in rural and underserved regions), and rising awareness of chronic respiratory management
• The non-home care segment dominated the Europe and Middle East and Africa medical oxygen cylinder market, with 68.2% market share in 2024, due to high demand from hospitals, emergency care, and ambulatory services

Report Scope and Europe and Middle East and Africa Medical Oxygen Cylinder Market Segmentation        

Europe and Middle East and Africa Medical Oxygen Cylinder Market Trends

Rising Demand Driven by Homecare and Emergency Respiratory Needs

• A significant and accelerating trend in the Europe and Middle East and Africa medical oxygen cylinder market is the increasing demand for lightweight, portable, and high-capacity cylinders that can be used in both clinical and homecare settings. This trend is driven by rising rates of chronic respiratory conditions such as COPD, asthma, and post-COVID complications
  • For instance, in Europe, an increasing number of elderly patients are shifting toward home-based oxygen therapy, prompting manufacturers to develop compact medical oxygen cylinders with longer duration and enhanced portability. In the Middle East and Africa, governments and NGOs are working to expand access to oxygen supply infrastructure in underserved regions
• Modern medical oxygen cylinders now feature advanced valve systems and pressure regulators that enhance user safety and delivery accuracy. These improvements allow patients and caregivers to better manage oxygen therapy without clinical supervision, reducing dependence on hospital facilities
• Furthermore, demand is growing for refillable and cost-efficient solutions, especially in regions with logistical challenges. Healthcare systems are emphasizing the availability of refill stations and mobile oxygen delivery services to meet patient needs in remote areas
• The trend toward more patient-centric, decentralized respiratory care is reshaping how oxygen is delivered across Europe, the Middle East, and Africa. This shift is supported by healthcare policies encouraging home treatment and outpatient support for chronic respiratory patients
• Major players such as Linde plc, Air Liquide, and Worthington Industries are focusing on developing medical-grade cylinders that adhere to regional safety regulations while offering extended usage times, rugged construction, and ease of transport for both ambulatory and stationary use
• The demand for medical oxygen cylinders that offer enhanced safety, portability, and compliance with healthcare standards is expected to rise steadily, as more patients and providers seek reliable solutions to support chronic care and emergency response in diverse healthcare settings

Europe and Middle East and Africa Medical Oxygen Cylinder Market Dynamics

Driver

Growing Need Due to Rising Respiratory Illnesses and Home-Based Oxygen Therapy Adoption

• The increasing prevalence of chronic respiratory conditions such as COPD, asthma, and post-COVID-19 complications across Europe, the Middle East, and Africa is a significant driver for the heightened demand for medical oxygen cylinders
  • For instance, in April 2024, Onity, Inc. (a Honeywell International, Inc. subsidiary) announced an advancement in IoT-based self-storage and facility security, including technologies that can also support secure medical gas storage environments. Innovations in this space are expected to indirectly contribute to safer distribution and storage of oxygen cylinders, enhancing supply chain confidence in the region
• As awareness of respiratory health risks grows, especially in aging populations and pollution-heavy urban areas, patients and healthcare providers are increasingly shifting toward home-based oxygen therapy, which requires reliable and portable medical oxygen cylinders
• Furthermore, the growing emphasis on decentralized healthcare and outpatient recovery models is making oxygen cylinders an integral component of homecare ecosystems. Patients are seeking devices that offer easy handling, compact design, and extended oxygen delivery capacity
• The convenience of using portable oxygen cylinders for travel, daily use, or emergency response, along with their compatibility with regulators and flowmeters, is propelling adoption in both personal and institutional applications. The trend towards self-administered therapies and increasing accessibility of refill and exchange services are also contributing to market growth

Restraint/Challenge

Concerns Regarding Supply Chain Stability and High Refill Costs

• Concerns surrounding the supply chain disruptions and cost volatility of medical-grade oxygen pose significant challenges to broader market penetration across the Europe and Middle East and Africa regions. During recent health crises, including COVID-19, several countries experienced critical shortages in oxygen supply, highlighting weaknesses in cylinder manufacturing and distribution networks
  • For instance, high-profile reports of oxygen cylinder shortages during the pandemic—particularly in parts of Africa and Eastern Europe—have prompted healthcare systems to revisit oxygen logistics, creating hesitancy among providers to rely solely on cylinder-based solutions
• Addressing these concerns requires robust supply chain planning, investment in domestic production, and regional stockpiling strategies. Manufacturers are working on building local partnerships and deploying mobile oxygen generation units to bridge gaps during emergencies
• Another challenge is the high recurring cost of refills, especially in remote or rural regions where centralized refill stations are limited. This can be a barrier for low-income patients or healthcare institutions operating under budget constraints
• While technological innovations are improving oxygen cylinder efficiency and portability, the initial and operational costs can still hinder adoption, particularly in under-resourced health systems
• Overcoming these challenges through public-private partnerships, subsidized refill programs, and policy-driven healthcare infrastructure expansion will be crucial for sustained market growth in the Europe and Middle East and Africa medical oxygen cylinder market

Europe and Middle East and Africa Medical Oxygen Cylinder Market Scope

The market is segmented on the basis of product, technology, application, usability, end user, and distribution channel.

• By Product

On the basis of product, the Europe and Middle East and Africa medical oxygen cylinder market is segmented into portable oxygen cylinder and stationary oxygen cylinder. The portable oxygen cylinder segment held the largest market share of 59.3% in 2024, attributed to the rising preference for mobile, home-based oxygen therapy and the growing aging population across Europe and the Middle East. These cylinders are widely used for COPD and other respiratory conditions, offering convenience, mobility, and ease of use.

The stationary oxygen cylinder segment is projected to witness the fastest CAGR of 6.9% from 2025 to 2032, driven by their cost-effectiveness for long-term use in hospitals and home-care settings and increasing adoption for chronic conditions requiring high-volume oxygen delivery.

• By Technology

On the basis of technology, the Europe and Middle East and Africa medical oxygen cylinder market is segmented into continuous flow and pulse flow. The continuous flow segment dominated the market with the largest revenue share of 63.7% in 2024, owing to its widespread application in hospitals and critical care units where a constant oxygen supply is essential.

The pulse flow segment is expected to grow at the highest CAGR of 7.4% during 2025–2032, due to its oxygen-saving efficiency and growing preference in portable devices used in ambulatory and travel settings.

• By Application

On the basis of application, the Europe and Middle East and Africa medical oxygen cylinder market is segmented into chronic obstructive pulmonary disease (COPD), pneumonia, lung cancer, asthma, respiratory distress syndrome, sleep apnea, anesthesia, and others. The chronic obstructive pulmonary disease (COPD) segment held the largest share of 38.6% in 2024, driven by the high prevalence of the disease, especially among elderly and smoking populations in Europe.

The sleep apnea segment is forecasted to exhibit the fastest growth rate of 7.9% from 2025 to 2032, attributed to the rising diagnosis rate and use of supplemental oxygen as part of sleep therapy.

• By Usability

On the basis of usability, the Europe and Middle East and Africa medical oxygen cylinder market is segmented into non-home care and home-care. The non-home care segment dominated with 68.2% market share in 2024, due to high demand from hospitals, emergency care, and ambulatory services.

The home-care segment is expected to grow at the highest CAGR of 8.2% during the forecast period, supported by an increase in chronic respiratory disease management at home and government support for home-based healthcare services.

• By End User

On the basis of end user, the Europe and Middle East and Africa medical oxygen cylinder market is segmented into hospitals, standalone ambulance services, home-care settings, and others. The hospitals segment captured the largest revenue share of 49.8% in 2024, owing to their role as the primary point of care for critical respiratory illnesses and surgeries requiring oxygen support.

The home-care settings segment is poised to witness the fastest CAGR of 8.5% during the forecast period, due to the increasing shift toward decentralized care models and preference for non-institutional care environments.

• By Distribution Channel

On the basis of distribution channel, the Europe and Middle East and Africa medical oxygen cylinder market is segmented into third party distributors, direct tender, and others. The direct tender segment dominated with 54.1% share in 2024, driven by high-volume procurement by public healthcare facilities and government initiatives.

The third-party distributor segment is projected to grow steadily during the forecast period, due to its strong presence in supplying oxygen cylinders to private healthcare providers, clinics, and individual consumers.

Europe and Middle East and Africa Medical Oxygen Cylinder Market Regional Analysis

• Europe dominated the Europe and Middle East and Africa medical oxygen cylinder market with the largest revenue share of 38.4% in 2024, driven by rising demand for high-quality respiratory care products, increasing geriatric population, and advancements in hospital and home-based oxygen therapy infrastructure
• Consumers in the region prioritize reliability, safety, and efficiency in oxygen delivery systems, leading to increased adoption of medical oxygen cylinders across hospitals, ambulatory surgical centers, and home healthcare settings
• This growth is further supported by favorable government reimbursement policies, heightened awareness of chronic respiratory conditions such as COPD and asthma, and the growing prevalence of home-based therapy as part of post-acute care strategies

Germany Medical Oxygen Cylinder Market Insight

The Germany medical oxygen cylinder market held a significant share in the European market in 2024, underpinned by its advanced healthcare infrastructure and a rising burden of chronic respiratory diseases. The country’s strong medical equipment manufacturing base and growing demand for portable oxygen cylinders for home care are driving market expansion. Government initiatives focused on aging population care and long-term respiratory support are further stimulating product adoption.

U.K. Medical Oxygen Cylinder Market Insight

The U.K. medical oxygen cylinder market is anticipated to expand at a robust CAGR over the forecast period, driven by an increasing number of patients requiring long-term oxygen therapy (LTOT), especially among the elderly. The National Health Service (NHS) continues to promote access to homecare oxygen services, and the post-pandemic emphasis on respiratory health has accelerated the use of portable oxygen cylinders in both home and clinical settings.

France Medical Oxygen Cylinder Market Insight

The France medical oxygen cylinder market is experiencing steady growth in the medical oxygen cylinder market due to a well-established public healthcare system and growing demand for durable and lightweight oxygen therapy equipment. The expansion of domiciliary care services and increasing public-private partnerships in healthcare delivery are also contributing to sustained product demand.

Italy Medical Oxygen Cylinder Market Insight

The Italy medical oxygen cylinder market is witnessing increased deployment of medical oxygen cylinders, particularly in response to the rising cases of chronic obstructive pulmonary disease and age-related respiratory ailments. Supportive government programs promoting in-home respiratory care and telemedicine are facilitating oxygen cylinder adoption in rural and suburban areas.

Middle East and Africa Medical Oxygen Cylinder Market Insight

The Middle East and Africa (MEA) medical oxygen cylinder market is witnessing notable growth due to rising healthcare investments, increasing prevalence of respiratory diseases such as asthma and COPD, and expanding access to essential medical supplies in both urban and remote areas. Governments across the region are enhancing healthcare infrastructure and emergency response systems, particularly after the COVID-19 pandemic highlighted the importance of oxygen availability.

Saudi Arabia Medical Oxygen Cylinder Market Insight

The Saudi Arabia medical oxygen cylinder market held a significant share of the MEA market in 2024, driven by the Kingdom’s Vision 2030 initiatives to modernize healthcare services and expand respiratory care capacity. Investments in public and private hospitals, rising elderly population, and a focus on emergency medical preparedness are all contributing to the increased adoption of medical oxygen cylinders across the country.

U.A.E. Medical Oxygen Cylinder Market Insight

The United Arab Emirates medical oxygen cylinder market is rapidly expanding its medical oxygen cylinder market, supported by its advanced healthcare infrastructure, rising demand for portable and refillable oxygen solutions, and a growing focus on homecare services. The presence of international manufacturers and strong logistics capabilities ensure high availability of quality oxygen cylinders throughout the region.

Europe and Middle East and Africa Medical Oxygen Cylinder Market Share

The Europe and Middle East and Africa Medical Oxygen Cylinder industry is primarily led by well-established companies, including:

• Koninklijke Philips N.V. (Netherlands)
• Niterra Co., Ltd. (Japan)
• Linde plc (Ireland)
• Supera Anesthesia Innovations (U.S.)
• Medical Depot, Inc. (U.S.)
• GCE Group (Sweden)
• Chart Industries (U.S.)
• Uflow Automation India (India)
• NAREENA LIFESCIENCES PRIVATE LIMITED (India)
• HERSILL (Spain)
• AMS Composite Cylinders (U.K.)
• Gulf Cryo (Kuwait)
• Al-Barrak Group (Saudi Arabia)
• Besco Manufactures Hospital (India)
• SHENYANG CANTA MEDICAL TECH. CO., LTD. (China)
• bluAqua Service GmbH & Co. (Germany)
• Me.Ber. srl. (Italy)
• OrientMed International (China)
• Foshan Keyhub Electronic Industries Co., Ltd. (China)
• Royax (Czech Republic)
• ULTRA CONTROLO (Portugal)

Latest Developments in Europe and Middle East and Africa Medical Oxygen Cylinder Market

• In October 2023, Forbes Healthcare named Nidek Medical Products' NUVO Lite Oxygen Concentrator the "Best Quiet Operation" Oxygen Concentrator for 2023. It is recognized for its low-power consumption, lightweight design, compact size and wide range of outlet flow volume options. The NUVO Lite underscores the company's dedication to delivering high-quality, cost-effective and user-friendly medical devices. This recognition further solidifies Nidek's position as an industry leader and enhances its image in the healthcare sector
• In May 2023, Drive DeVilbiss International unveiled the 1060AW, an energy-efficient 10-liter oxygen concentrator, designed specifically for challenging environments. This innovative device addresses the unique requirements of rural and semi-urban areas, marking a significant advancement in oxygen therapy at both primary and secondary health levels. This benefited the company by expanding its product portfolio result in more product offering ultimately increase revenue
• In April 2023, Czech Republic-based medical equipment company Royax have expanded its operations to Gothenburg, Sweden with a focus on growing in Sweden, northern Europe and beyond. Headed by entrepreneur Abbas Bafkar, the Swedish subsidiary benefits from the country's high-quality standards of life and global credibility. Royax, known for its innovative patient transport equipment and ambulances received support from life science investment advisor Iris Öhrn, aiding in building a strong business case and integrating into the local innovation ecosystem
• In February 2022, Everest Kanto Cylinder Limited (EKC) unveiled plans for substantial capacity expansion in India and Europe, reflecting a positive outlook with a Rs. 215 crore investment during FY23-24, EKC anticipates a combined revenue potential of Rs. 712 crore from expansion. The company has successfully completed Phase I of its Rs. 35 crore brownfield expansion project, enhancing production lines and output. The ongoing initiatives position EKC for robust growth, aiming to complete Phase II by the second quarter of FY23

SKU-70443